Publication | Open Access

Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways

Metabolic SyndromeBiochemistryMedicinePhysiologyDiabetesStreptozotocin-treated RatsMetabolic RegulationAmpk/acc2 Signaling PathwaysPharmacologyInsulin SignalingGastrointestinal Peptide HormoneHealth Sciences